Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to ETFdb.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience
Etfdb logo
  • ETF
  • PSCH
    Pricing Data
    $73.92
    Change: $1.5 (0.02%)
    Time: 12/09/16
    Previous Close: $72.42
  • Category
  • Health & Biotech Equities
Last Updated:

Profile

Vitals

Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $56.89
  • 52 Week Hi: $76.98
  • AUM: $175.2 M
  • Shares: 2.4 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 20,918
  • 3 Month Avg. Volume: 20,095

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

This fund gives investors exposure to the small cap health care industry, a market segment that has both value and growth characteristics. Securities in this corner of the market can be also be prone to quick shifts in sentiment thanks to changing government regulations or policies. Furthermore, many companies in this corner of the market are unprofitable and rely on FDA drug approval in order to snap back into the green, a very risky proposition. With that being said, PSCH gives investors a nice mix of biotech, pharma, medical tech, and facility companies spreading risk around the various corners of the health care world. However, it should be noted that the fund does still have singificant concentrattion in its top ten holdings as these companies make up close to one third of total assets, rather high considering the fund only has 70 securities in total. As a result, investors should consider this fund only if they are looking to tactically tilt towards the sector or round out exposure to the health care segment.

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for PSCH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

PSCH Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity B- n/a
Expenses A n/a
Performance
Volatility
Dividend
Concentration

Knowledge Centers

PSCH In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb Category.

PSCH Holdings

Filings Data as of: Dec 04, 2016
Sign Up for Pro to Unlock Data Sign Up

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb Category.

Number of Holdings
Rank:
77
Category Low
Category High
% Assets in Top 10
Rank:
30.21%
Category Low
Category High

Asset Allocation

Asset Percentage
U.S. Stocks 100.02%
International Stocks 0.0%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash -0.02%
Other 0.0%

Sector Breakdown

Sector Percentage
Health Care 85.65%
Technology 10.09%
Industrials 3.88%
Financial Services 0.4%
Real Estate 0.0%
Consumer Defensive 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Communication Services 0.0%
Utilities 0.0%

Market Cap Breakdown

Market Cap Percentage
Giant 0.0%
Large 0.0%
Medium 0.0%
Small 49.09%
Micro 50.93%

Region Breakdown

Region Percentage
U.S. 100.02%
Middle East 0.0%
Australia 0.0%
Japan 0.0%
Asia (Developed) 0.0%
Africa 0.0%
Europe 0.0%
Latin America 0.0%
Canada 0.0%
Asia (Emerging) 0.0%

Market Tier Breakdown

Region Percentage
Developed 100.02%
Emerging 0.0%

Country Breakdown

Country Percentage
United States 100.02%
Other -0.02%

PSCH Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

ETF Average
0.573%
ETF Wtd. Average
0.25%
Category Average
0.48%
Expense Ratio
Rank:
0.29%
Category Low
Category High

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:

PSCH Performance

This section shows how this ETF has performed relative to its peer group ETFdb Category.

1 Week Return
Rank:
4.23%
Category Low
Category High
4 Week Return
Rank:
4.55%
Category Low
Category High
13 Week Return
Rank:
0.64%
Category Low
Category High
26 Week Return
Rank:
3.54%
Category Low
Category High
Year to Date Return
Rank:
2.85%
Category Low
Category High
1 Year Return
Rank:
3.95%
Category Low
Category High
3 Year Return
Rank:
38.33%
Category Low
Category High
5 Year Return
Rank:
154.59%
Category Low
Category High

Brought to You by Mitre Media


Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of PSCH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

PSCH Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
Rank:
32.76
Category Low
Category High

As of Aug 25 2016

PSCH Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
Dividend
$1.44
Dividend Date
2014-12-24
Annual Dividend Rate
n/a
Annual Dividend Yield
Rank:
2.01%
Category Low
Category High

As of Aug 25, 2016

PSCH Technicals

Sign Up for Pro to Unlock Data Sign Up

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb Category.

5 Day Volatility
Rank:
13.53%
Category Low
Category High
20 Day Volatility
Rank:
16.45%
Category Low
Category High
50 Day Volatility
Rank:
20.89%
Category Low
Category High
200 Day Volatility
Rank:
17.87%
Category Low
Category High
Beta
Rank:
0.96
Category Low
Category High
Standard Deviation
Rank:
4.26%
Category Low
Category High

Technicals

  • 20 Day MA: $72.14
  • 60 Day MA: $71.63
  • MACD 15 Period: 1.60
  • MACD 100 Period: 1.45
  • Williams % Range 10 Day: 4.07
  • Williams % Range 20 Day: 2.95
  • RSI 10 Day: 66
  • RSI 20 Day: 59
  • RSI 30 Day: 56
  • Ultimate Oscillator: 62

Bollinger Brands

  • Lower Bollinger (10 Day): $70.66
  • Upper Bollinger (10 Day): $73.67
  • Lower Bollinger (20 Day): $70.57
  • Upper Bollinger (20 Day): $73.60
  • Lower Bollinger (30 Day): $64.22
  • Upper Bollinger (30 Day): $76.03

Support & Resistance

  • Support Level 1: $73.63
  • Support Level 2: $73.33
  • Resistance Level 1: $74.14
  • Resistance Level 2: $74.35

Stochastic

  • Stochastic Oscillator %D (1 Day): 64.41
  • Stochastic Oscillator %D (5 Day): 75.46
  • Stochastic Oscillator %K (1 Day): 57.69
  • Stochastic Oscillator %K (5 Day): 63.35

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.